- Home
- TNMG vs CTMX Comparison
TNMG vs CTMX Comparison
Compare TNMG & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNMG
- CTMX
- Stock Information
- Founded
- TNMG 2023
- CTMX 2008
- Country
- TNMG Japan
- CTMX United States
- Employees
- TNMG N/A
- CTMX N/A
- Industry
- TNMG
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- TNMG
- CTMX Health Care
- Exchange
- TNMG NYSE
- CTMX Nasdaq
- Market Cap
- TNMG 93.7M
- CTMX 85.3M
- IPO Year
- TNMG N/A
- CTMX 2015
- Fundamental
- Price
- TNMG $2.93
- CTMX $0.90
- Analyst Decision
- TNMG
- CTMX Buy
- Analyst Count
- TNMG 0
- CTMX 6
- Target Price
- TNMG N/A
- CTMX $5.77
- AVG Volume (30 Days)
- TNMG 48.3K
- CTMX 1.0M
- Earning Date
- TNMG 01-01-0001
- CTMX 03-10-2025
- Dividend Yield
- TNMG N/A
- CTMX N/A
- EPS Growth
- TNMG N/A
- CTMX N/A
- EPS
- TNMG N/A
- CTMX 0.16
- Revenue
- TNMG N/A
- CTMX $126,617,000.00
- Revenue This Year
- TNMG N/A
- CTMX $22.55
- Revenue Next Year
- TNMG N/A
- CTMX N/A
- P/E Ratio
- TNMG N/A
- CTMX $5.31
- Revenue Growth
- TNMG N/A
- CTMX 33.66
- 52 Week Low
- TNMG $1.89
- CTMX $0.79
- 52 Week High
- TNMG $34.08
- CTMX $5.85
- Technical
- Relative Strength Index (RSI)
- TNMG N/A
- CTMX 43.26
- Support Level
- TNMG N/A
- CTMX $0.82
- Resistance Level
- TNMG N/A
- CTMX $0.92
- Average True Range (ATR)
- TNMG 0.00
- CTMX 0.06
- MACD
- TNMG 0.00
- CTMX 0.00
- Stochastic Oscillator
- TNMG 0.00
- CTMX 51.32
About TNMG TNL MEDIAGENE
TNL Mediagene is a comprehensive media and data platform providing news and commentary on current events, business, technology, lifestyle and sports.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.